Skip to main content

Advertisement

SpringerLink
Log in

The role of insulin-like growth factor I–II receptor on development of pleomorphic adenoma

  • Head and Neck
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Pleomorphic adenoma is a slow-growing salivary gland tumor frequently arising from the parotid gland. In this study, we investigated the role of the insulin-like growth factor I–II receptor (IGFI–IIR) levels on the development of parotid gland pleomorphic adenomas. The study included 20 males and 20 females who had superficial parotidectomy with a histopathological diagnosis of pleomorphic adenoma in Fırat University Otorhinolaryngology Clinic between 2000 and 2011. The ages of the patients ranged between 20 and 50 years. The control tissues were obtained unilaterally from the parotid glands of five female and five male cadavers during autopsy, and consisted of 0.5 × 0.5 cm sized normal parotid gland tissues. The expression of IGFI–IIR were measured in both tumor and tumor-free normal parotid tissue in the study group while only the normal parotid tissues were studied in the cadavers. Primary polyclonal antibodies against IGFI–IIR were used with “Streptavidin–Biotin Complex” method for immunohistochemical staining of both the study and the control groups’ tissue sections. In this study, the IGFI–IIR levels were found significantly higher in the pleomorphic adenoma tissue (p < 0.05). In addition, IGFI–IIR expression was greater in normal parotid tissues of the study group when compared to the normal parotid tissues of the cadavers. However, the difference was not statistically significant (p > 0.017). Greater expression for IGFI–IIR in pleomorphic adenoma when compared to normal parotid tissues of the patients and the cadavers suggests that IGFI–II may be important factors in the development of pleomorphic adenoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ayoub OM, Bhatia K, Mal RK (2002) Pleomorphic adenoma of the parotid gland: is long-term follow-up needed? Auris Nasus Larynx 29:283–285

    Article  PubMed  Google Scholar 

  2. Patrick JB (2004) Pleomorphic salivary adenoma of the parotid gland: which operation to perform? Curr Opin Otolaryngol Head Neck Surg 12:69–70

    Article  Google Scholar 

  3. Rodriguez-Bigas MA, Sako K, Razack MS, Shedd DP, Bakamjian VY (1991) Benign parotid tumors: a 24 year-experience. J Surg Oncol 46:159–161

    Article  CAS  PubMed  Google Scholar 

  4. Ahn MS, Hayashi GM, Hilsinger RL, Lalwani AK (1999) Familial mixed tumors of the parotid gland. Head Neck 21:772–775

    Article  CAS  PubMed  Google Scholar 

  5. Seifert G, Langrock I, Donath K (1976) A pathological classification of pleomorphic adenoma of the salivary glands. HNO 24:415–426

    CAS  PubMed  Google Scholar 

  6. Short DW, Pullar P (1956) Giant parotid tumor; with report of a case. J R Coll Surg 3:240–248

    Google Scholar 

  7. Lamson G, Giudice L, Rosenfelt RG (1991) The insulin-like growth factor binding proteins structural and molecular relationships. Growth Factors 5:19–28

    Article  CAS  PubMed  Google Scholar 

  8. Kato H, Faria TN, Stannard B, Roberts CT Jr, LeRoith D (1993) Role of tyrosine kinase activity in signal transduction the insulin-like growth factor-I (IGF-I) receptor. J Biol Chem 265:2655–2661

    Google Scholar 

  9. Nolan CM, Kyle JW, Watanabe H, Sly WS (1990) Binding of insulin-like growth factor II (IGF-II) by human cation-independent mannose 6-phosphate receptor/IGF- II receptor expressed in receptor-de cient mouse L cells. Cell Regul 17:197–213

    Google Scholar 

  10. Le Roith D, Werner H, Beitner-Johnson D, Roberts CT (1995) Molecular and cellular aspects of the insulin- like growth factor I receptor. Endocr Rev 16:143–163

    Article  Google Scholar 

  11. Buchman C, Stringer SP, Mendenhall WM, Parsons JT, Jordan JR, Cassisi NJ (1994) Pleomorphic adenoma: effect of tumors pillandina de quateresection on tumor recurrence. Laryngoscope 104:1231

    CAS  PubMed  Google Scholar 

  12. Seifert G, Miehlke A, Haubrich J, Chilla R (1986) Diseases of the salivary glands. Thieme, New York, pp 22–86

    Google Scholar 

  13. Minshall C, Arkins S, Straza J, Conners J, Dantzer R, Freund GG et al (1997) IL-4 and insulin-like growth factor-I inhibit the decline in Bcl-2 and promote the survival of IL-3-deprived myeloid progenitors. J Immunol 159:1225–1232

    CAS  PubMed  Google Scholar 

  14. Kaklamani VG, Linos A, Kaklamani E, Markaki I, Mantzoros C (1999) Age, sex and smoking are predictors of circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3. J Clin Oncol 17:813–817

    Article  CAS  PubMed  Google Scholar 

  15. Jenkins PJ, Fairclough PD, Richards T, Lowe DG, Monson J, Grossman A, Wass JA, Besser M (1997) Acromegaly, colonic polyps and carcinoma. Clin Endocrinol 47:17–22

    Article  CAS  Google Scholar 

  16. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P et al (1998) Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279:563–566

    Article  CAS  PubMed  Google Scholar 

  17. Yu H, Spitz MR, Mistry J, Gu J, Hong WK, Wu X (1999) Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst 91:151–156

    Article  CAS  PubMed  Google Scholar 

  18. Maiorano E, Ciampolil OA, Viale G, Maisonneuve P, Ambrosi A, Triggiani V et al (2000) Insulin-like growth factor 1 expression in thyroid tumors. Appl Immunohistochem Mol Morphol 8:110–119

    CAS  PubMed  Google Scholar 

  19. Maiorano E, Ambrosi A, Giorgino R, Fersini M, Police L, Ciampolil OA (1994) Insulin like growth factor 1 (IGF-1) in multi nodular goiters: a possible pathogenetic factor. Pathol Res Pract 190:1012–1016

    Article  CAS  PubMed  Google Scholar 

  20. Maciel RM, Kimura ET, Takahaski MH, Lopes MH, Mesquita MI, Moses AC, Alberti VN (1995) Insulin-like growth factor I in human thyroid tissue: specific localization by immunohistochemistry and in situ hybridization. Endocr Pathol 6:207–215

    Article  CAS  PubMed  Google Scholar 

  21. Reeve AE, Eccles MR, Wilkins RJ, Bell GI, Millow LJ (1985) Expression of insulin like growth factor-II transcripts in Wilms’ tumour. Nature 317:258–260

    Article  CAS  Google Scholar 

  22. Cullen KJ, Smith HS, Hill S, Rosen N, Lippman ME (1991) Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions. Cancer Res 51:4978–4985

    CAS  PubMed  Google Scholar 

  23. Sullivan KA, Castle VP, Hanash SM, Feldman EL (1995) Insulin-like growth factor II in the pathogenesis of human neuroblastoma. Am J Pathol 147:1790–1798

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Li S-L, Goko H, Xu ZD, Kimura G, Sun Y, Mark H et al (1998) Expression of insulin-like growth factor (IGF)-II in human prostate, breast, bladder, and paraganglioma tumors, vol 291. Springer, Berlin, pp 469–479

    Google Scholar 

  25. Ogawa Y, Kishino M, Atsumi Y, Kimoto M, Fukuda Y, Ishida T (2003) NaokuniI juhin N. Plasma cytoid cells in salivary gland pleomorphic adenomas: evidence of luminal cell differentiation. Virchows Arch 5:625–634

    Article  Google Scholar 

  26. Ogawa Y, Miyauchi M, Takata T, Vuhahula E, Ijuhin N, Nikar H (1993) Proliferative activity of salivary gland pleomorphic adenomas and myoepitheliomas as evaluated by the proliferating cell nuclear antigen (PCNA) labeling index (LI). J Oral Pathol Med 22:447–450

    Article  CAS  PubMed  Google Scholar 

  27. Myoken Y, Okamoto T, Sato JD, Kan M, McKeehan WL, Fujihara M, Takada K (1997) Immunohistochemical localization of fibroblast growth factor-1 (FGF-1), FGF-2 and fibroblast growth factor receptor-1 (FGfR-1) in pleomorphic adenoma of the salivary glands. J Oral Pathol Med 26:17–22

    Article  CAS  PubMed  Google Scholar 

  28. Glas AS, Hollema H, Nap RE, Plukker JT (2002) Expression of estrogen receptor, progesterone receptor, and insulin-like growth factor receptor-1 and of MIB-1 in patients with recurrent pleomorphic adenoma of the parotid gland. Cancer 94:2211–2216

    Article  CAS  PubMed  Google Scholar 

  29. Voz ML, Agten NS, Van de Ven WJ, Kas K (2000) PLAG1, the main trans location target in pleomorphic adenoma of the salivary glands, is a positive regulator of IGF-II. Cancer Res 60:106–113

    CAS  PubMed  Google Scholar 

  30. Xudong Z, Weihua R, Wenjun Y, Yi W, Hui K, Long W et al (2006) Wnt pathway is involved in pleomorphic adenomas induced by over expression of PLAG1 in transgenic mice. Int J Cancer 118:643–648

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otorhinolaryngology, School of Medicine, Fırat University, Elazig, Turkey

    Ibrahim Arslan, Erol Keles, Turgut Karlidag, Irfan Kaygusuz, Orkun Eroglu, Koray Yuksel & Sinasi Yalcin

  2. Department of Pathology, School of Medicine, Fırat University, Elazig, Turkey

    I. Hanifi Ozercan

  3. Department of Forensic Medicine, School of Medicine, Fırat University, Elazig, Turkey

    Mehmet Tokdemir

  4. Fırat Üniversitesi Tıp Fakultesi Hastanesi, Kulak Burun ve Boğaz Hastalıkları Klinigi, Kat:7, 23119, Elazig, Turkey

    Orkun Eroglu

Authors
  1. Ibrahim Arslan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Erol Keles
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. Hanifi Ozercan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mehmet Tokdemir
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Turgut Karlidag
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Irfan Kaygusuz
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Orkun Eroglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Koray Yuksel
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Sinasi Yalcin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Orkun Eroglu.

Ethics declarations

Ethical approval

This article does not contain any studies with animals performed by any of the authors.

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Arslan, I., Keles, E., Ozercan, I.H. et al. The role of insulin-like growth factor I–II receptor on development of pleomorphic adenoma. Eur Arch Otorhinolaryngol 274, 3443–3447 (2017). https://doi.org/10.1007/s00405-017-4644-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-017-4644-2

Keywords

Search

Navigation